Digitoxin and its analogs as novel cancer therapeutics (original) (raw)

• Prassas I, Diamandis EP: Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 2008,7(11):926–935. 10.1038/nrd2682
  Article CAS PubMed Google Scholar
• Newman RA, Yang P, Pawlus AD, Block KI: Cardiac Glycosides as Novel Cancer Therapeutic Agents. Mol Interv 2008,8(1):36–49. 10.1124/mi.8.1.8
  Article CAS PubMed Google Scholar
• Huxtable RJ: The Erroneous Pharmacology of a Cat. Mol Interv 2001,1(2):75–77.
  CAS PubMed Google Scholar
• Gheorghiade M, van Veldhuisen DJ, Colucci WS: Contemporary Use of Digoxin in the Management of Cardiovascular Disorders. Circulation 2006,113(21):2556–2564. 10.1161/CIRCULATIONAHA.105.560110
  Article PubMed Google Scholar
• Rahimtoola SH, Tak T: The use of digitalis in heart failure. Curr Probl Cardiol 1996,21(12):781–853. 10.1016/S0146-2806(96)80001-6
  Article CAS PubMed Google Scholar
• Schonfeld W: The lead structure in cardiac glycosides is 5[beta],14[beta]-androstane-3[beta]14-diol. Naunyn Schmiedebergs Arch Pharmacol 1985, 329: 414–426. 10.1007/BF00496377
  Article CAS PubMed Google Scholar
• Melero CP, Medardea M, Feliciano AS: A short review on cardiotonic steroids and their aminoguanidine analogues. Molecules 2000, 5: 51–81. 10.3390/50100051
  Article CAS Google Scholar
• Langenhan JM, Peters NR, Guzei IA, Hoffmann M, Thorson JS: Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc Natl Acad Sci USA 2005,102(35):12305–12310. 10.1073/pnas.0503270102
  Article CAS PubMed Central PubMed Google Scholar
• Iyer AKV, Zhou M, Azad N, Elbaz H, Wang L, Rogalsky DK, Rojanasakul Y, O'Doherty GA, Langenhan JM: A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis. ACS Med Chem Lett 2010,1(7):326–330. 10.1021/ml1000933
  Article CAS PubMed Central PubMed Google Scholar
• Barry W, Hasin Y, Smith T: Sodium pump inhibition, enhanced calcium influx via sodium-calcium exchange, and positive inotropic response in cultured heart cells. Circ Res 1985,56(2):231–241.
  Article CAS PubMed Google Scholar
• Kaplan JH: Biochemistry of Na, K-ATPase. Annu Rev Biochem 2002, 71: 511–535. 10.1146/annurev.biochem.71.102201.141218
  Article CAS PubMed Google Scholar
• Kaplan JG: Membrane cation transport and the control of proliferation of mammalian cells. Annu Rev Physiol 1978, 40: 19–41. 10.1146/annurev.ph.40.030178.000315
  Article CAS PubMed Google Scholar
• Brewer H: Historical perspectives on health. J R Soc Promot Health 2004,124(4):184–187. 10.1177/146642400412400412
  Article PubMed Google Scholar
• Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K: The Cooperative Interaction of Two Different Signaling Pathways in Response to Bufalin Induces Apoptosis in Human Leukemia U937 Cells. J Biol Chem 1996,271(24):14067–14073. 10.1074/jbc.271.24.14067
  Article CAS PubMed Google Scholar
• Yeh JY, Huang WJ, Kan SF, Wang PS: Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 2003,54(2):112–124. 10.1002/pros.10172
  Article CAS PubMed Google Scholar
• Han KQ: Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol 2007, 13: 3374–3379.
  Article CAS PubMed Central PubMed Google Scholar
• Shiratori O: Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies. Gann 1967,58(6):521–528.
  CAS PubMed Google Scholar
• López-Lázaro M: Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved. Expert Opin Ther Targets 2007,11(8):1043–1053. 10.1517/14728222.11.8.1043
  Article PubMed Google Scholar
• Stenkvist B: Cardiac glycosides and breast cancer. Lancet 1979, 1: 563.
  Article CAS PubMed Google Scholar
• Stenkvist B: Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol 1980, 2: 49–54.
  CAS PubMed Google Scholar
• Stenkvist B: Cardiac glycosides and breast cancer, revisited. N Engl J Med 1982, 306: 484.
  CAS PubMed Google Scholar
• Stenkvist B: Is digitalis a therapy for breast carcinoma? Oncol Rep 1999, 6: 493–496.
  CAS PubMed Google Scholar
• Goldin AG, Safa AR: Digitalis and cancer. Lancet 1984, 1: 1134.
  Article CAS PubMed Google Scholar
• Hashimoto S, Jing Y, Kawazoe N, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K: Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk Res 1997,21(9):875–883. 10.1016/S0145-2126(97)00061-1
  Article CAS PubMed Google Scholar
• Jing Y: Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res 1994, 85: 645–651. 10.1111/j.1349-7006.1994.tb02408.x
  Article CAS PubMed Google Scholar
• Kamano Y, Kotake A, Hashima H, Inoue M, Morita H, Takeya K, Itokawa H, Nandachi N, Segawa T, Yukita A, et al.: Structure-cytotoxic activity relationship for the toad poison bufadienolides. Bioorg Med Chem 1998,6(7):1103–1115. 10.1016/S0968-0896(98)00067-4
  Article CAS PubMed Google Scholar
• Kawazoe N, Watabe M, Masuda Y, Nakajo S, Nakaya K: Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene 1999, 18: 2413–2421. 10.1038/sj.onc.1202555
  Article CAS PubMed Google Scholar
• Masuda Y: Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res 1995, 19: 549–556. 10.1016/0145-2126(95)00031-I
  Article CAS PubMed Google Scholar
• Bielawski K, Winnicka K, Bielawska A: Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull 2006,29(7):1493–1497. 10.1248/bpb.29.1493
  Article CAS PubMed Google Scholar
• Johansson S, Lindholm P, Gullbo J, Larsson P, Bohlin L, Claeson P: Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anti-Cancer Drugs 2001,12(5):475–483. 10.1097/00001813-200106000-00009
  Article CAS PubMed Google Scholar
• Lopez-Lazaro M, Pastor N, Azrak SS, Ayuso MJ, Austin CA, Cortes F: Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J Nat Prod 2005,68(11):1642–1645. 10.1021/np050226l
  Article CAS PubMed Google Scholar
• Winnicka K, Bielawski K, Bielawska A, Miltyk W: Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. Arch Pharm Res 2007, 30: 1216–1224. 10.1007/BF02980262
  Article CAS PubMed Google Scholar
• Winnicka K, Bielawski K, Bielawska A, Miltyk W: Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts. Nat Prod Res 2010,24(3):274–285. 10.1080/14786410902991878
  Article CAS PubMed Google Scholar
• Yeh JY, Huang WJ, Kan SF, Wang PS: Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells. J Urol 2001,166(5):1937–1942. 10.1016/S0022-5347(05)65724-2
  Article CAS PubMed Google Scholar
• Zhang HF, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammer H, Chang D, Pili R, et al.: Digoxin and other cardiac glycosides inhibit HIF-1 alpha synthesis and block tumor growth. Proc Natl Acad Sci USA 2008,105(50):19579–19586. 10.1073/pnas.0809763105
  Article CAS PubMed Central PubMed Google Scholar
• Elbaz HA, Stueckle TA, Wang H-YL, O'Doherty G, Lowry DT, Sargent LM, Wang L, Dinu CZ, Rojanasakul Y: Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells. Toxicology and Applied Pharmacology 2012,258(1):51–60. 10.1016/j.taap.2011.10.007
  Article CAS PubMed Central PubMed Google Scholar
• Wang H-YL, Rojanasakul Y, O‚ÄôDoherty GA: Synthesis and Evaluation of the α-d-/α-l-Rhamnosyl and Amicetosyl Digitoxigenin Oligomers as Antitumor Agents. ACS Med Chem Lett 2011,2(4):264–269. 10.1021/ml100290d
  Article CAS PubMed Central PubMed Google Scholar
• Wang H-YL, Wu B, Zhang Q, Kang S-W, Rojanasakul Y, O‚ÄôDoherty GA: C5'-Alkyl Substitution Effects on Digitoxigenin α-l-Glycoside Cancer Cytotoxicity. ACS Med Chem Lett 2011,2(4):259–263. 10.1021/ml100291n
  Article CAS PubMed Central PubMed Google Scholar
• Wang H-YL, Xin W, Zhou M, Stueckle TA, Rojanasakul Y, O'Doherty GA: Stereochemical Survey of Digitoxin Monosaccharides. ACS Med Chem Lett 2010,2(1):73–78.
  Article CAS PubMed Central Google Scholar
• Wang Z, Zheng M, Li Z, Li R, Jia L, Xiong X, Southall N, Wang S, Xia M, Austin CP, et al.: Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition. Cancer Res 2009,69(16):6556–6564. 10.1158/0008-5472.CAN-09-0891
  Article CAS PubMed Central PubMed Google Scholar
• Winnicka K, Bielawski K, Bielawska A, Miltyk W: Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts. Nat Prod Res 2010,24(3):274–285. 10.1080/14786410902991878
  Article CAS PubMed Google Scholar
• Afaq F, Saleem M, Aziz MH, Mukhtar H: Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion markers in CD-1 mouse skin by oleandrin. Toxicol Appl Pharmacol 2004,195(3):361–369. 10.1016/j.taap.2003.09.027
  Article CAS PubMed Google Scholar
• Felth J, Rickardson L, Rosen J, Wickstrom M, Fryknas M, Lindskog M, Bohlin L, Gullbo J: Cytotoxic Effects of Cardiac Glycosides in Colon Cancer Cells, Alone and in Combination with Standard Chemotherapeutic Drugs. J Nat Prod 2009,72(11):1969–1974. 10.1021/np900210m
  Article CAS PubMed Google Scholar
• Gupta RS, Chopra A, Stetsko DK: Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). J Cell Physiol 1986,127(2):197–206. 10.1002/jcp.1041270202
  Article CAS PubMed Google Scholar
• Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB: Oleandrin suppresses activation of nuclear transcription factor-kappa B, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res 2000,60(14):3838–3847.
  CAS PubMed Google Scholar
• McConkey DJ, Lin Y, Nutt LK, Ozel HZ, Newman RA: Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 2000,60(14):3807–3812.
  CAS PubMed Google Scholar
• Nasu S, Milas L, Kawabe S, Raju U, Newman RA: Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process. Cancer Lett 2002,185(2):145–151. 10.1016/S0304-3835(02)00263-X
  Article CAS PubMed Google Scholar
• Newman RA: Oleandrin-mediated oxidative stress in human melanoma cells. J Exp Ther Oncol 2006, 5: 167–181.
  CAS PubMed Google Scholar
• Newman RA, Kondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, Johansen M, Yang P: Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Integr Cancer Ther 2007, 6: 354–364. 10.1177/1534735407309623
  Article CAS PubMed Google Scholar
• Pathak S, Multani AS, Narayan S, Kumar V, Newman RA: AnvirzelTM, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anti-Cancer Drugs 2000,11(6):455–463. 10.1097/00001813-200007000-00006
  Article CAS PubMed Google Scholar
• Raghavendra PB, Sreenivasan Y, Manna SK: Oleandrin induces apoptosis in human, but not in murine cells: Dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity. Mol Immunol 2007,44(9):2292–2302. 10.1016/j.molimm.2006.11.009
  Article CAS PubMed Google Scholar
• Schoner W, Scheiner-Bobis G: Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007,293(2):C509-C536. 10.1152/ajpcell.00098.2007
  Article CAS PubMed Google Scholar
• Smith JA, Madden T, Vijjeswarapu M, Newman RA: Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem Pharmacol 2001,62(4):469–472. 10.1016/S0006-2952(01)00690-6
  Article CAS PubMed Google Scholar
• Sreenivasan Y, Raghavendra PB, Manna SK: Oleandrin-mediated expression of fas potentiates apoptosis in tumor cells. J Clin Immunol 2006,26(4):308–322. 10.1007/s10875-006-9028-0
  Article CAS PubMed Google Scholar
• Sreenivasan Y, Sarkar A, Manna SK: Oleandrin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 and potentiates apoptosis induced by ceramide. Biochem Pharmacol 2003,66(11):2223–2239. 10.1016/j.bcp.2003.07.010
  Article CAS PubMed Google Scholar
• Wang XM, Plomley JB, Newman RA, Cisneros A: LC/MS/MS analyses of an oleander extract for cancer treatment. Anal Chem 2000,72(15):3547–3552. 10.1021/ac991425a
  Article CAS PubMed Google Scholar
• Yang PY, Menter DG, Cartwright C, Chan D, Dixon S, Suraokar M, Mendoza G, Llansa N, Newman RA: Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na, K-ATPase alpha subunits as drug targets. Mol Cancer Ther 2009,8(8):2319–2328. 10.1158/1535-7163.MCT-08-1085
  Article CAS PubMed Google Scholar
• Kometiani P, Liu L, Askari A: Digitalis-Induced Signaling by Na+/K + -ATPase in Human Breast Cancer Cells. Mol Pharmacol 2005,67(3):929–936.
  Article CAS PubMed Google Scholar
• Lawrence TS: Ouabain sensitizes tumor cells but not normal cells to radiation. Int J Radiat Oncol Biol Phys 1988,15(4):953–958. 10.1016/0360-3016(88)90132-0
  Article CAS PubMed Google Scholar
• Winnicka K, Bielawski K, Bielawska A, Surazy ≈ Ñski A: Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells. Biol Pharm Bull 2008,31(6):1131–1140. 10.1248/bpb.31.1131
  Article CAS PubMed Google Scholar
• Xie Z, Kometiani P, Liu J, Li J, Shapiro JI, Askari A: Intracellular reactive oxygen species mediate the linkage of Na+/K + -ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 1999,274(27):19323–19328. 10.1074/jbc.274.27.19323
  Article CAS PubMed Google Scholar
• Xu J-W, Jin R-M, Wang Y-R, Lin W, Meng B: Effects of ouabain at different concentrations on growth of leukemia cells. Zhongguo Dang Dai Er Ke Za Zhi 2009,11(4):259–262.
  CAS PubMed Google Scholar
• Contreras RG, Flores-Maldonado C, Lázaro A, Shoshani L, Flores-Benitez D, Larré I, Cereijido M: Ouabain Binding to Na+/K + -ATPase Relaxes Cell Attachment and Sends a SpecificSignal (NACos) to the Nucleus. J Membr Biol 2004,198(3):147–158. 10.1007/s00232-004-0670-2
  Article CAS PubMed Google Scholar
• Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P: Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anti-Cancer Drugs 2001,12(5):475–483. 10.1097/00001813-200106000-00009
  Article CAS PubMed Google Scholar
• Schneider R: Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure. Clin Exp Hypertens 1998, 20: 593–599. 10.3109/10641969809053237
  Article CAS PubMed Google Scholar
• Winnicka K, Bielawski K, Bielawska A, Surazynski A: Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin a in human MCF-7 and MDA-MB-231 breast cancer cells. Biol Pharm Bull 2008,31(6):1131–1140. 10.1248/bpb.31.1131
  Article CAS PubMed Google Scholar
• Belz GG: Breithaupt-Gr√∂gler K, Osowski U: Treatment of congestive heart failure-current status of use of digitoxin. Eur J Clin Invest 2001,31(Suppl 2):10–17.
  Article PubMed Google Scholar
• Castle MC: Pharmacokinetics of digoxin and digitoxin in humans. Eastern virginia med sch/med col hamp rd 1977.
  Google Scholar
• BøHMER T, RøSETH A: Prolonged digitoxin half-life in very elderly patients. Age Ageing 1998,27(2):222–224. 10.1093/ageing/27.2.222
  Article PubMed Google Scholar
• Smith TW: Digitalis toxicity: epidemiology and clinical use of serum concentration measurements. Am J Med 1975,58(4):470–476. 10.1016/0002-9343(75)90118-7
  Article CAS PubMed Google Scholar
• Williams JF Jr, Potter RD, Mathew B: Effects of arrhythmia-producing concentrations of digitoxin on mechanical performance of cat myocardium. Am Heart J 1983,105(1):21–25. 10.1016/0002-8703(83)90273-9
  Article CAS PubMed Google Scholar
• Haux J: Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 1999,53(6):543–548. 10.1054/mehy.1999.0985
  Article CAS PubMed Google Scholar
• Schatzmann HJ, Rass B: Inhibition of the active Na-K-transport and Na-K-activated membrane ATP-ase of erythrocyte stroma by ouabain. Helv Physiol Pharmacol Acta 1965, 65: C47-C49.
  CAS PubMed Google Scholar
• Chang HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK, Liu CP, Chou KJ, Chen WC, Su W, et al.: Tamoxifen-induced increases in cytoplasmic free Ca-2+ levels in human breast cancer cells. Breast Cancer Res Treat 2002,71(2):125–131. 10.1023/A:1013807731642
  Article CAS PubMed Google Scholar
• Koumura T, Nakamura C, Nakagawa Y: Role of calcium-induced mitochondrial hydroperoxide in induction of apoptosis of RBL2H3 cells with eicosapentaenoic acid treatment. Free Radic Res 2005,39(10):1083–1089. 10.1080/10715760500264654
  Article CAS PubMed Google Scholar
• Pigozzi D, Tombal B, Ducret T, Vacher P, Gailly P: Role of store-dependent influx of Ca2+ and efflux of K + in apoptosis of CHO cells. Cell Calcium 2004,36(5):421–430. 10.1016/j.ceca.2004.04.002
  Article CAS PubMed Google Scholar
• Xie Z, Cai T: Na+/K + ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function. Mol Interv 2003,3(3):157–168. 10.1124/mi.3.3.157
  Article CAS PubMed Google Scholar
• Wang XQ: Apoptotic insults impair Na+, K + -ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci 2003, 116: 2099–2110. 10.1242/jcs.00420
  Article CAS PubMed Google Scholar
• Liu L, Abramowitz J, Askari A, Allen JC: Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype. Am J Physiol Heart Circ Physiol 2004, 287: H2173-H2182. 10.1152/ajpheart.00352.2004
  Article CAS PubMed Google Scholar
• Barwe SP: Novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell 2005, 16: 1082–1094. 10.1091/mbc.E04-05-0427
  Article CAS PubMed Central PubMed Google Scholar
• Larre I, Lazaro A, Contreras RG, Balda MS, Matter K, Flores-Maldonado C, Ponce A, Flores-Benitez D, Rincon-Heredia R, Padilla-Benavides T, et al.: Ouabain modulates epithelial cell tight junction. Proc Natl Acad Sci 2010,107(25):11387–11392. 10.1073/pnas.1000500107
  Article CAS PubMed Central PubMed Google Scholar
• Bulavin DV, Fornace AJ Jr: p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 2004, 92: 95–118.
  Article CAS PubMed Google Scholar
• Cagnol S, Chambard J-C: ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 2009,277(1):2–21.
  Article PubMed CAS Google Scholar
• de Paula RM, Lamb TM, Bennett L, Bell-Pedersen D: A connection between MAPK pathways and circadian clocks. Cell Cycle 2008,7(17):2630–2634. 10.4161/cc.7.17.6516
  Article CAS PubMed Central PubMed Google Scholar
• Gotoh I, Nishida E: Signal transductions by the MAP kinase cascades. Nippon Rinsho 1998,56(7):1779–1783.
  CAS PubMed Google Scholar
• Han J, Sun P: The pathways to tumor suppression via route p38. Trends Biochem Sci 2007,32(8):364–371. 10.1016/j.tibs.2007.06.007
  Article CAS PubMed Google Scholar
• Keyse SM: Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 2008,27(2):253–261. 10.1007/s10555-008-9123-1
  Article CAS PubMed Google Scholar
• Khavari TA, Rinn J: Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia. Cell Cycle 2007,6(23):2928–2931. 10.4161/cc.6.23.4998
  Article CAS PubMed Google Scholar
• Bolós V, Gasent JM, López-Tarruella S, Grande E: The dual kinase complex FAK-Src as a promising therapeutic target in cancer. Onco Targets Ther 2010, 3: 83–97.
  Article PubMed Central PubMed Google Scholar
• Burnham MR, Bruce-Staskal PJ, Harte MT, Weidow CL, Ma A, Weed SA, Bouton AH: Regulation of c-SRC activity and function by the adapter protein CAS. Mol Cell Biol 2000,20(16):5865–5878. 10.1128/MCB.20.16.5865-5878.2000
  Article CAS PubMed Central PubMed Google Scholar
• Chen C-Y, Chang C-Y, Liu H-J, Liao M-H, Chang C-I, Hsu J-L, Shih W-L: Apoptosis induction in BEFV-infected Vero and MDBK cells through Src-dependent JNK activation regulates caspase-3 and mitochondria pathways. Vet Res 2010.,41(2):
• Di Florio A, Capurso G, Milione M, Panzuto F, Geremia R: Delle Fave G, Sette C: Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer 2007,14(1):111–124. 10.1677/erc.1.01318
  Article CAS PubMed Google Scholar
• Götz R: Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression. Cancer Cell Int 2008,8(1):7. 10.1186/1475-2867-8-7
  Article PubMed Central PubMed CAS Google Scholar
• Liu Y, Gao L, Gelman IH: SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis. BMC Cancer 2006,6(1):105. 10.1186/1471-2407-6-105
  Article PubMed Central PubMed CAS Google Scholar
• Owen KA, Abshire MY, Tilghman RW, Casanova JE, Bouton AH: FAK Regulates Intestinal Epithelial Cell Survival and Proliferation during Mucosal Wound Healing. PLoS One 2011.,6(8):
• Tian M, Schiemann W: The TGF-β Paradox in Human Cancer: An Update. Future Oncol 2009,5(2):259–271. 10.2217/14796694.5.2.259
  Article CAS PubMed Central PubMed Google Scholar
• Williams SP, Karnezis T, Achen MG, Stacker SA: Targeting lymphatic vessel functions through tyrosine kinases. J Angiogenes Res 2010, 2: 13–13. 10.1186/2040-2384-2-13
  Article PubMed Central PubMed CAS Google Scholar
• Liang M, Cai T, Tian J, Qu W, Xie ZJ: Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J Biol Chem 2006, 281: 19709–19719. 10.1074/jbc.M512240200
  Article CAS PubMed Google Scholar
• Langenhan JM, Engle JM, Slevin LK, Fay LR, Lucker RW, Smith KR, Endo MM: Modifying the glycosidic linkage in digitoxin analogs provides selective cytotoxins. Bioorg Med Chem Lett 2008,18(2):670–673. 10.1016/j.bmcl.2007.11.058
  Article CAS PubMed Google Scholar
• Zhou M, O'Doherty G: The De novo Synthesis of Oligosaccharides - Application to the Medicinal Chemistry SAR Study of Digitoxin. ChemInform Abstract 2008.,39(27):
• Zhou M, O'Doherty G: The De Novo Synthesis of Oligosaccharides: Application to the Medicinal Chemistry SAR-Study of Digitoxin. Curr Top Med Chem 2008, 8: 114–125. 10.2174/156802608783378828
  Article CAS PubMed Google Scholar
• Mohammadi K, Kometiani P, Xie Z, Askari A: Role of protein kinase C in the signal pathways that link Na+/K + -ATPase to ERK1/2. J Biol Chem 2001, 276: 42050–42056. 10.1074/jbc.M107892200
  Article CAS PubMed Google Scholar
• Yuan Z: Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell 2005, 16: 4034–4045. 10.1091/mbc.E05-04-0295
  Article CAS PubMed Central PubMed Google Scholar
• Liu L, Askari A: On the importance and mechanism of amplification of digitalis signal through Na+/K+-ATPase. Cell Mol Biol (Noisy-le-Grand) 2006,52(8):28–30.
  CAS Google Scholar
• Kometiani P, Li J, Gnudi L, Kahn BB, Askari A, Xie Z: Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem 1998,273(24):15249–15256. 10.1074/jbc.273.24.15249
  Article CAS PubMed Google Scholar
• Peng M, Huang L, Xie Z, Huang WH, Askari A: Partial inhibition of Na+/K + -ATPase by ouabain induces the Ca2 + -dependent expressions of early-response genes in cardiac myocytes. J Biol Chem 1996,271(17):10372–10378. 10.1074/jbc.271.17.10372
  Article CAS PubMed Google Scholar
• Schoner W, Scheiner-Bobis G: Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007,293(2):C509-C536. 10.1152/ajpcell.00098.2007
  Article CAS PubMed Google Scholar
• Dueñas-González A, García-López P, Herrera LA, Medina-Franco JL, González-Fierro A, Myrna C: The prince and the pauper. A tale of anticancer targeted agents. Mol Cancer 2008,7(1):82. 10.1186/1476-4598-7-82
  Article PubMed Central PubMed CAS Google Scholar
• Shull MM, Pugh DG, Lingrel JB: Characterization of the human Na, K-ATPase alpha 2 gene and identification of intragenic restriction fragment length polymorphisms. J Biol Chem 1989,264(29):17532–17543.
  CAS PubMed Google Scholar
• Jagielska J, Salguero G, Schieffer B, Bavendiek U: Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis? Atherosclerosis 2009,206(2):390–396. 10.1016/j.atherosclerosis.2009.03.019
  Article CAS PubMed Google Scholar
• Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, Yang Q, Jacobson KA, Heldman E, Huang W, Jozwik C, et al.: Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci USA 2004,101(20):7693–7698. 10.1073/pnas.0402030101
  Article CAS PubMed Central PubMed Google Scholar
• Yang Q, Huang W, Jozwik C, Lin Y, Glasman M, Caohuy H, Srivastava M, Esposito D, Gillette W, Hartley J, et al.: Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci USA 2005,102(27):9631–9636. 10.1073/pnas.0504097102
  Article CAS PubMed Central PubMed Google Scholar
• Bamberger AM, Milde-Langosch K, R√∂ssing E, Goemann C, L√∂ning T: Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 2001,127(9):545–550. 10.1007/s004320100255
  Article CAS PubMed Google Scholar
• Dumesic PA, Scholl FA, Barragan DI, Khavari PA: Erk1/2 MAP kinases are required for epidermal G2/M progression. J Cell Biol 2009,185(3):409–422. 10.1083/jcb.200804038
  Article CAS PubMed Central PubMed Google Scholar
• Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG: The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis. Mol Cancer Res 2007,5(2):109–120. 10.1158/1541-7786.MCR-06-0311
  Article CAS PubMed Google Scholar
• Crombez L, Morris MC, Dufort S, Aldrian-Herrada G, Nguyen Q, Mc Master G, Coll J-L, Heitz F, Divita G: Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res 2009,37(14):4559–4569. 10.1093/nar/gkp451
  Article CAS PubMed Central PubMed Google Scholar
• Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M, Strebhardt K: Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004,23(34):5843–5852. 10.1038/sj.onc.1207757
  Article CAS PubMed Google Scholar
• Chae SW, Sohn JH, Kim D-H, Choi YJ, Park YL, Kim K, Cho YH, Pyo J-S, Kim JH: Overexpressions of Cyclin B1, cdc2, p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications. Yonsei Med J 2011,52(3):445–453. 10.3349/ymj.2011.52.3.445
  Article PubMed Central PubMed Google Scholar
• Cooper WA, Kohonen-Corish MRJ, McCaughan B, Kennedy C, Sutherland RL, Lee CS: Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Histopathology 2009,55(1):28–36. 10.1111/j.1365-2559.2009.03331.x
  Article PubMed Google Scholar
• Egloff AM, Weissfeld J, Land SR, Finn OJ: Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer. Ann N Y Acad Sci 2005, 1062: 29–40. 10.1196/annals.1358.005
  Article CAS PubMed Google Scholar
• Kim D-H: Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer. Yonsei Med J 2007,48(4):694–700. 10.3349/ymj.2007.48.4.694
  Article PubMed Central PubMed Google Scholar
• Wong Y-F, Cheung T-H, Tsao GSW, Lo KWK, Yim S-F, Wang VW, Heung MMS, Chan SCS, Chan LKY, Ho TWF, et al.: Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006,118(10):2461–2469. 10.1002/ijc.21660
  Article CAS PubMed Google Scholar
• Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H: The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 2004,15(2):252–256. 10.1093/annonc/mdh073
  Article CAS PubMed Google Scholar
• De Souza CP, Ellem KA, Gabrielli BG: Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp Cell Res 2000,257(1):11–21. 10.1006/excr.2000.4872
  Article CAS PubMed Google Scholar
• Stark G, Taylor W: Control of the G2/M transition. Mol Biotechnol 2006,32(3):227–248. 10.1385/MB:32:3:227
  Article CAS PubMed Google Scholar
• Dabrowski A, Filip A, Zgodzi ≈ Ñski W, Dabrowska M, Pola ≈ Ñska D, W√ ≥ jcik M, Zinkiewicz K, Wallner G: Assessment of prognostic significance of cytoplasmic survivin expression in advanced oesophageal cancer. Folia Histochem Cytobiol 2004,42(3):169–172.
  CAS PubMed Google Scholar
• Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S: Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 2003,200(5):620–626. 10.1002/path.1388
  Article CAS PubMed Google Scholar
• He L, Hou M, Zhang J, Xu N, Chen P: Subcellular localization of survivin in non-small cell lung cancer. Ai Zheng 2009,28(9):955–960.
  CAS PubMed Google Scholar
• Y-j R, Q-y Z: Expression of survivin and its clinical significance in non-small cell lung cancer. Beijing Da Xue Xue Bao 2005,37(5):504–507.
  Google Scholar
• Yang H, Fu J-h, Hu Y, Huang W-z, Zheng B, Wang G: Relationship between survivin expression and chemosensitivity of human lung cancer cells. Zhonghua Yi Xue Za Zhi 2007,87(27):1934–1937.
  CAS PubMed Google Scholar
• Zhou J-M, Zhou J-H, Deng Z-H, Zheng H, Jiang H-Y, Cao H-Q: Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005,30(5):544–548.
  CAS PubMed Google Scholar
• Beardmore VA, Ahonen LJ, Gorbsky GJ, Kallio MJ: Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity. J Cell Sci 2004,117(Pt 18):4033–4042.
  Article CAS PubMed Google Scholar
• Beltrami E, Plescia J, Wilkinson JC, Duckett CS, Altieri DC: Acute Ablation of Survivin Uncovers p53-dependent Mitotic Checkpoint Functions and Control of Mitochondrial Apoptosis. J Biol Chem 2004,279(3):2077–2084. 10.1074/jbc.M309479200
  Article CAS PubMed Google Scholar
• Mita AC, Mita MM, Nawrocki ST, Giles FJ: Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics. Clin Cancer Res 2008,14(16):5000–5005. 10.1158/1078-0432.CCR-08-0746
  Article CAS PubMed Google Scholar
• Wolanin K, Piwocka K: Role of survivin in mitosis. Postepy Biochem 2007,53(1):10–18.
  CAS PubMed Google Scholar
• Colnaghi R, Wheatley SP: Liaisons between survivin and Plk1 during cell division and cell death. J Biol Chem 2010,285(29):22592–22604. 10.1074/jbc.M109.065003
  Article CAS PubMed Central PubMed Google Scholar
• Lens SMA, Wolthuis RMF, Klompmaker R, Kauw J, Agami R, Brummelkamp T, Kops G, Medema RH: Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J 2003,22(12):2934–2947. 10.1093/emboj/cdg307
  Article CAS PubMed Central PubMed Google Scholar
• Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC, Altieri DC: Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1999,1(8):461–466. 10.1038/70242
  Article CAS PubMed Google Scholar
• Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998,396(6711):580–584. 10.1038/25141
  Article CAS PubMed Google Scholar
• Castedo M, Perfettini J-L, Roumier T, Andreau K, Medema R, Kroemer G: Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004,23(16):2825–2837. 10.1038/sj.onc.1207528
  Article CAS PubMed Google Scholar
• Okada H, Mak TW: Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004,4(8):592–603. 10.1038/nrc1412
  Article CAS PubMed Google Scholar
• Vakifahmetoglu H, Olsson M, Zhivotovsky B: Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008,15(7):1153–1162. 10.1038/cdd.2008.47
  Article CAS PubMed Google Scholar
• Barre' B, Perkins ND: A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J 2007,26(23):4841–4855. 10.1038/sj.emboj.7601899
  Article CAS Google Scholar
• Bartek J, Lukas J: Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3: 421–429. 10.1016/S1535-6108(03)00110-7
  Article CAS PubMed Google Scholar
• Zhou B-BS, Bartek J: Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat Rev Cancer 2004,4(3):216–225. 10.1038/nrc1296
  Article CAS PubMed Google Scholar
• Zhou B-BS, Sausville EA: Drug discovery targeting Chk1 and Chk2 kinases. Prog Cell Cycle Res 2003, 5: 413–421.
  PubMed Google Scholar
• Haas M, Wang H, Tian J, Xie Z: Src-mediated inter-receptor cross-talk between the Na+/K + -ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 2002, 277: 18694–18702. 10.1074/jbc.M111357200
  Article CAS PubMed Google Scholar